Jubilant Ingrevia Ltd Stock Analysis

BSE: 543271 | NSE: JUBLINGREA | Chemicals | Small Cap

BSE Share Price 22-Sep-2023 18:02
470.70 0.45 (0.10%)

DeciZen - Make an Informed Decision on Jubilant Ingrevia

Overall Rating

1. Quality

2. Valuation


3. Price Trend

Semi Strong

Jubilant Ingrevia Price Chart

P/E Ratio ( SA) :
Market Cap :
7,490.2 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Jubilant Ingrevia Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Jubilant Ingrevia Ltd is a below average quality company.

2. Is Jubilant Ingrevia Ltd undervalued or overvalued?

The key valuation ratios of Jubilant Ingrevia Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Jubilant Ingrevia Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Jubilant Ingrevia Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Jubilant Ingrevia:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Jubilant Ingrevia Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

ROCE % 143.1%4.9%21%11.3%-
Value Creation Index NA-0.60.6-0.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 06694,8604,5604,402
YoY Gr. Rt. %-NA626.6%-6.2%-
Adj EPS -
YoY Gr. Rt. %-NA833.7%-42.6%-
BVPS (₹) -2.398.9124.4135.3138.7
Adj Net Profit -0.249.7464266232
Cash Flow from Ops. 0104587446-
Debt/CF from Ops.


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA-6.2%
Adj EPS NANANA-42.6%
Share Price - - - -8.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity % 143.16.326.112.910.6
Op. Profit Mgn % 014.917.111.310.6
Net Profit Mgn %
Debt to Equity
Working Cap Days 03341061280
Cash Conv. Cycle 01522380

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 10.60%

Sales growth has been subdued in last 3 years 0.00%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at -9.85%

Latest Financials - Jubilant Ingrevia Ltd.

Standalone Consolidated
TTM EPS (₹) 14.6 17.9
TTM Sales (₹ Cr.) 4,402 4,650
BVPS (₹.) 138.7 170.8
Reserves (₹ Cr.) 2,193 2,704
P/BV 3.39 2.75
PE 32.31 26.19
From the Market
52 Week Low / High (₹) 350.80 / 592.45
All Time Low / High (₹) 243.60 / 877.95
Market Cap (₹ Cr.) 7,490
Equity (₹ Cr.) 15.9
Face Value (₹) 1
Industry PE 38.7

Management X-Ray of Jubilant Ingrevia :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Jubilant Ingrevia

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


Jubilant Ingrevia Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Jubilant Ingrevia on 22-Sep-2023 18:02 is : 470.7.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 22-Sep-2023 18:02 the market cap of Jubilant Ingrevia stood at ₹ 7,490.2.
The latest PE ratio of Jubilant Ingrevia as of 22-Sep-2023 18:02 is 32.31.
The latest PB ratio of Jubilant Ingrevia as of 22-Sep-2023 18:02 is 3.39
The 52-week high of Jubilant Ingrevia is ₹ 592.5 and the 52-week low is ₹ 350.8.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Jubilant Ingrevia is ₹ 4,402 ( Cr.) .

About Jubilant Ingrevia Ltd

Jubilant Ingrevia is a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with its customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. Jubilant Ingrevia is the demerged pharma and life sciences business of Jubilant Lifesciences and listed on the exchanges in FY21.

Business area of the company

The company offers a broad portfolio of high-quality ingredients that find application in a wide range of industries. The company’s portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis.

Product and services

Speciality Chemicals
  • Speciality Ingredients
  • Fine Chemicals
  • Crop Protection Chemicals
  • CDMO
Nutrition & Health Solutions
  • Nutrition & Health Ingredients
  • Animal Nutrition & Health Solutions
  • Human Nutrition & Health Solutions
Life Science Chemicals
  • Life Science Ingredients
  • Speciality Ethanol
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now